We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CUERVO:BMVBecle, S.A.B. de C.V. Analysis

Data as of 2026-03-17 - not real-time

MX$15.09

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Becle, S.A.B. de C.V. (CUERVO) trades at MXN 15.09, well below its 20‑day (MXN 17.41), 50‑day (MXN 19.22) and 200‑day (MXN 21.20) moving averages, indicating a bearish technical backdrop. RSI at 20.3 signals oversold conditions, while the MACD remains bearish, suggesting limited short‑term upside but a potential for a technical rebound. The company’s fundamentals show a low PE of 6.3, PB of 0.77 and a dividend yield of 2.63% with a modest 16% payout, underscoring a defensible income stream. However, Q4 FY2025 revealed a 14% YoY decline in net sales (8.4% FX‑adjusted), and revenue growth is negative at –14.1%, highlighting near‑term earnings pressure. Despite the sales dip, margins remain strong (gross 56%, operating 21%, profit 20%) and free cash flow is robust at MXN 6.6 bn, supporting dividend sustainability. The balance sheet carries MXN 20.8 bn of debt against MXN 11.1 bn of cash, yielding a high debt‑to‑equity ratio, but liquidity is adequate. A DCF fair value of MXN 22.29 implies ~67% upside, and analyst consensus (11 analysts) rates the stock as a Buy with a median target of MXN 27.
Overall, the stock appears significantly undervalued with solid cash generation and a stable dividend, yet faces short‑term revenue headwinds and elevated price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages and bearish MACD
  • Oversold RSI suggesting limited upside
  • Recent sales decline impacting earnings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial valuation gap to DCF fair value
  • Strong cash flow and sustainable dividend
  • Analyst consensus and upside potential

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Resilient brand portfolio in consumer defensive sector
  • Stable profitability and low beta indicating defensive characteristics
  • Long‑term upside from undervaluation and dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth-14.10%
Profit Margin20.07%
P/E Ratio6.3
ROE12.63%
ROA5.53%
Debt/Equity29.63
P/B Ratio0.8
Op. Cash FlowMX$8.2B
Free Cash FlowMX$6.6B

Technical Analysis

TrendBearish
RSI20.3
SupportMX$0.00
ResistanceMX$19.39
MA 20MX$17.41
MA 50MX$19.22
MA 200MX$21.20
MACDBearish
VolumeIncreasing
Fear & Greed Index80.82

Valuation

Fair ValueMX$22.29
Target PriceMX$25.31
Upside/Downside67.72%
GradeUndervalued
TypeValue
Dividend Yield2.63%

Risk Assessment

Beta0.19
Volatility34.05%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.